People: Wright Medical Group Inc (WMGI.O)

WMGI.O on Nasdaq

24.76USD
12:04pm EDT
Price Change (% chg)

$0.12 (+0.49%)
Prev Close
$24.64
Open
$24.46
Day's High
$24.89
Day's Low
$24.45
Volume
112,955
Avg. Vol
338,716
52-wk High
$25.08
52-wk Low
$18.11

Search Stocks

Summary

Name Age Since Current Position

David Stevens

 60 2011 Independent Chairman of the Board

Robert Palmisano

 2011 President, Chief Executive Officer, Director

Lance Berry

 38 2009 Chief Financial Officer, Senior Vice President,

Timothy Davis

 41 2012 President - OrthoRecon

Eric Stookey

 41 2012 President - Extremities

Pascal Girin

 2012 Chief Operating Officer, Executive Vice President

Daniel Garen

 39 2012 Senior Vice President, Chief Compliance Officer

James Lightman

 54 2011 Senior Vice President, General Counsel, Secretary

Edward Steiger

 60 2010 Senior Vice President - Human Resources

William Griffin

 63 2008 Senior Vice President - Global Operations

Julie Tracy

 50 2011 Senior Vice President, Chief Communications Officer

John Treace

 40 2010 Senior Vice President - Global Marketing and U.S. Sales

Jennifer Walker

 44 2011 Senior Vice President - Process Improvement

Douglas Watson

 68 2013 Director

Gary Blackford

 54 2008 Independent Director

Martin Emerson

 49 2006 Independent Director

Lawrence Hamilton

 54 2007 Independent Director

Ronald Labrum

 55 2011 Independent Director

John Miclot

 53 2007 Independent Director

Amy Paul

 60 2008 Independent Director

Robert Quillinan

 64 2006 Independent Director
» Insider Trading

Biographies

Name Description

David Stevens

 Mr. David D. Stevens is Independent Chairman of the Board of Wright Medical Group, Inc. He has been a director since 2004. Mr. Stevens served as the company's interim Chief Executive Officer from April 4, 2011 to September 17, 2011. He has been a private investor since 2006. Mr. Stevens was the Chief Executive Officer of Accredo Health Group, Inc., a subsidiary of Medco Health Solutions, Inc., from 2005 to 2006. He was the Chairman of the Board and Chief Executive Officer of Accredo Health, Inc. from 1996 to 2005. Mr. Stevens was the President and Chief Operating Officer of the predecessor companies of Accredo Health from their inception in 1983 until 1996. He is a director of Medco Health Solutions, Inc. and Thomas & Betts Corporation, both public companies.

Robert Palmisano

 Mr. Robert J. Palmisano serves as President, Chief Executive Officer, Director of Wright Medical Group Inc., since September 17, 2011. Prior to joining the company, Mr. Palmisano served as President and Chief Executive Officer of ev3, Inc., a global endovascular device company, from April 2008 to July 2010, when it was acquired by Covidien plc. From 2003 to 2007, Mr. Palmisano was President and Chief Executive Officer of IntraLase Corp. Before joining IntraLase, Mr. Palmisano was President and Chief Executive Officer of MacroChem Corporation from 2001 to 2003 Mr. Palmisano is currently a Venture Partner of SV Life Sciences and serves on the Board of Directors of Bausch & Lomb and the Providence College Board of Trustees. During the past five years, Mr. Palmisano previously served on the Board of Directors of ev3, Inc., Osteotech, Inc., and Abbott Medical Options, Inc., all public companies.

Lance Berry

 Mr. Lance A. Berry is Chief Financial Officer, Senior Vice President of Wright Medical Group, Inc. since December 11, 2009. He joined the company in 2002, and, until his appointment as Chief Financial Officer, served as Vice President and Corporate Controller. Prior to joining the company, Mr. Berry served as audit manager with the Memphis office of Arthur Andersen LLP from 1995 to 2002. Mr. Berry received his Masters degree in Accounting from the University of Mississippi. Mr. Berry is a certified public accountant, inactive.

Timothy Davis

 Mr. Timothy E. Davis, Jr., has been appointed as President - OrthoRecon of Wright Medical Group Inc. effective November 06, 2012. Mr. Davis previously served as the company's Vice President, Business Development from 2006. He was a partner with MB Venture Partners, LLC, a medical technology and life sciences venture capital firm specializing in musculoskeletal diseases, from 2004 to 2006. Mr. Davis was Vice President of Vector Fund Management, a healthcare and life sciences venture capital firm, from 1997 to 2004. He was a Senior Consultant at Gemini Consulting Group, a healthcare consulting firm, from 1995 to 1997 and a Sales Specialist at Parke-Davis Company, a pharmaceutical company, from 1992 to 1994.

Eric Stookey

 Mr. Eric A. Stookey has been appointed as President - Extremities of Wright Medical Group Inc. effective November 06, 2012. Mr. Stookey has served the company in various other marketing and sales positions from 1995 to January 2010, including as the company's Vice President, North American Sales from 2007 to January 2010, as the company's Vice President – U.S. Sales from 2005 until 2007, as the company's Senior Director of Sales – Central Region from 2003 to 2005 and as the company's Director of Marketing for Joint Reconstruction Products from 2001 to 2003. He was employed by DePuy Orthopedics, Inc. from 1993 to 1995.

Pascal Girin

 Mr. Pascal E.R. Girin has been appointed as the Chief Operating Officer, Executive Vice President of Wright Medical Group, Inc., effective November 19, 2012. He previously served as President and Chief Executive Officer of Keystone Dental Inc. from February 2011 to June 2012. From October 2010 to February 2011, Mr. Girin served as Executive Vice President and Chief Operating Officer of Keystone Dental Inc. From July 2010 to September 2010, Mr. Girin served as Chief Operating Officer of ev3 Inc. following its acquisition by a wholly owned subsidiary of Covidien Group S.a.r.l. Prior to that time, Mr. Girin served as Executive Vice President and Chief Operating Officer of ev3 Inc. from January 2010 to July 2010, as Executive Vice President and President, Worldwide Neurovascular and International of ev3 Neurovascular Inc. from July 2008 to January 2010, as Senior Vice President and President, International of ev3 International from July 2005 to July 2008, and as General Manager, Europe of ev3 Inc. from September 2003 to July 2005. From September 1998 to August 2003, Mr. Girin served in various capacities at BioScience Europe Baxter Healthcare Corporation, most recently as Vice President. Mr. Girin received an engineering education at the French Ecole des Mines. From November 2010 until November 2, 2012, Mr. Girin had served as a director of Tornier, N.V., a publicly traded global medical device company, as well as a member of its Nominating, Corporate Governance and Compliance Committee.

Daniel Garen

 Mr. Daniel Garen serves as Senior Vice President, Chief Compliance Officer of Wright Medical Group, Inc., effective January 30, 2012. Prior to joining the company, Mr. Garen served in various legal, compliance and regulatory positions with Siemens AG. Mr. Garen served as Chief Compliance Officer and Senior Counsel from January 2007 to August 2010 and he most recently held the position of Vice President, Healthcare Policy and Clinical Affairs until January 2012 at Siemens Healthcare Sector US. Prior to joining Siemens, Mr. Garen held senior counsel and compliance officer positions with Bayer Healthcare from September 2003 to January 2007.

James Lightman

 Mr. James A. Lightman serves as Senior Vice President, General Counsel, Secretary of Wright Medical Group, Inc., since December 29, 2011. Prior to joining the company, Mr. Lightman served in various legal and executive positions with Bausch & Lomb Incorporated. From February 2008 to November 2009, Mr. Lightman served as Vice President and Assistant General Counsel of Bausch & Lomb, and most recently held the position of Vice President, Global Sales Operations until August 2011. From June 2007 to February 2008, he served as Vice President and General Counsel of Eyeonics, Inc. Prior to joining Eyeonics, Mr. Lightman served as Senior Vice President and General Counsel of IntraLase Corp. from February 2005 to April 2007.

Edward Steiger

 Mr. Edward A. Steiger serves as Senior Vice President - Human Resources of Wright Medical Group Inc., since January, 2010. He was previously the company's Vice President, Human Resources from 2008 to January 2010. He has ten years of experience in the medical device industry and 37 years of experience related to various aspects of human resources. Prior to joining the company, Mr. Steiger was employed by Sempra Energy as Vice President, Human Resources for its global businesses from 2003 to 2008. From 1998 to 2003, Mr. Steiger worked for Monsanto Company, most recently as its Vice President, Global Staffing. From 1992 to 1997, Mr. Steiger was Vice President, Human Resources for Tastemaker, a specialty chemical/flavor partnership between Mallinckrodt Inc. and Hercules Incorporated. From 1985 to 1992, Mr. Steiger held a number of key positions at Allergan, Inc. a global eye care pharmaceutical and medical device company.

William Griffin

 Mr. William L. Griffin, Jr., serves as Senior Vice President - Global Operations of Wright Medical Group Inc., since July 2008. Prior to joining the company, Mr. Griffin had global responsibility for all operations at Smith & Nephew, Inc. since 2002. From 1997 until 2002, he held positions at Johnson & Johnson Medical, including most recently serving as its Vice President and General Manager. Mr. Griffin began his career in the medical device industry with Becton, Dickinson and Company where he spent 23 years with the final position of Vice President of Global Supply Chain Services.

Julie Tracy

 Ms. Julie D. Tracy serves as Senior Vice President, Chief Communications Officer of Wright Medical Group, Inc., effective October 18, 2011. Ms. Tracy has more than 25 years of experience in the medical device industry in investor relations, corporate communications and marketing. She most recently served as Chief Communications Officer for Epocrates, Inc. Prior to Epocrates, Ms. Tracy was Senior Vice President and Chief Communications Officer for ev3 Inc., where she built a world-class investor relations program that was the highest ranked small cap medical device IR program by Institutional Investor in 2009 and 2010. Prior to ev3, Ms. Tracy held marketing and investor relations positions at Kyphon Inc. and Thoratec Corporation. Ms. Tracy holds a B.S. degree in business administration from the University of Southern California and received her MBA from Pepperdine University in Los Angeles. She is a member of the National Investor Relations Institute's Senior Roundtable.

John Treace

 Mr. John T. Treace serves as Senior Vice President - Global Marketing and U.S. Sales of Wright Medical Group Inc., since January 2010. Mr. Treace previously served as the company's Vice President, Biologics and Extremities Marketing from 2005 to January 2010. He served as the company's Vice President and General Manager – Biologics and Extremity Marketing from 2003 to 2005 and the Senior Director – Biologics Marketing from 2001 to 2003. Mr. Treace was the Director of Marketing of Medtronic Xomed, Inc., and its predecessor, Xomed Surgical Products, Inc., from 1996 to 2000. He was the Director of Marketing of TreBay Medical Corp. from 1994 to 1996.

Jennifer Walker

 Ms. Jennifer S. Walker serves as Senior Vice President - Process Improvement of Wright Medical Group Inc., since December 2011. Prior to this role, she had served as the Company’s Vice President & Corporate Controller since December 2009. Since joining the company's financial organization in 1993, she has also served as Assistant Controller, Director, Financial Reporting & Risk Management, Director, Corporate Tax & Risk Management and Tax Manager. Prior to joining the company, Ms. Walker was a senior tax accountant with Arthur Andersen LLP. Ms. Walker is a certified public accountant.

Douglas Watson

 Mr. Douglas G. Watson is Director of Wright Medical Group, Inc. Mr. Watson is currently the Chief Executive Officer of Pittencrieff Glen Associates, a leadership and consulting firm that he founded in 1999. Prior to that, Mr. Watson served as President and Chief Executive Officer of Novartis Corporation (the U.S. subsidiary of Novartis A.G.), President and Chief Executive Officer of Ciba-Geigy Corporation (which merged into Novartis Corporation in December 1996), President of the Ciba Pharmaceuticals Division and Senior Vice President of Planning and Business Development of Ciba's U.S. Pharmaceuticals Division. In all, Mr. Watson's career with Novartis spanned 33 years, having joined Geigy (UK) Ltd. in 1966. Mr. Watson currently serves as chairman of the board of OraSure Technologies, Inc., as a lead director of Dendreon Corporation, and a director of Delcath Systems, Inc., all public companies. Prior board memberships have included BioMimetic Therapeutics, Inc., Genta Incorporated, Javelin Pharmaceuticals, Inc., Engelhard Corporation and Summit Bank Corporation, all public companies, and Bionor Immuno AS and BZL Biologics Inc., both private companies.

Gary Blackford

 Mr. Gary D. Blackford serves as Independent Director of Wright Medical Group Inc., since May 2008. Since 2007, Mr. Blackford has served as Chairman of the Board of Directors of Universal Hospital Services, Inc. In addition to his role as Chairman, Mr. Blackford has been the President, Chief Executive Officer and a member of the Board of Directors of Universal Hospital Services, Inc. since 2003. From 2001 to 2002, Mr. Blackford was Chief Executive Officer for Curative Health Services Inc. From 1999 to 2001, Mr. Blackford served as Chief Executive Officer for ShopforSchool, Inc. He was the Chief Operating Officer for Value Rx from 1995 to 1998 and the Chief Operating Officer and Chief Financial Officer of MedIntel Systems Corporation from 1993 to 1994. Mr. Blackford is a director of Universal Hospital Services, Inc., a public reporting company, and served on the Board of Directors of Compex Technologies, Inc., a public reporting company, from 2005 until its acquisition by Encore Medical Corporation.

Martin Emerson

 Mr. Martin J. Emerson serves as Independent Director of Wright Medical Group Inc., since April 2006. He currently serves as President, Chief Executive Officer, and Director of Galil Medical, a private medical device company. He was the President and Chief Executive Officer and a director of American Medical Systems Holdings, Inc., a medical device company, from 2005 to 2008, where he also served as the President and Chief Operating Officer from 2004 to 2005, the Executive Vice President of Global Sales and Marketing and Chief Operating Officer from 2003 to 2004, and a Vice President and the General Manager of International from 2000 to 2002. Mr. Emerson has over 23 years of experience in the medical device industry. He was the General Manager and Finance Director in Singapore for Boston Scientific Corporation from 1998 to 2000. Mr. Emerson was the Vice President and Regional Financial Officer in Singapore for MasterCard International Incorporated from 1997 to 1998. He also held management positions with Baxter International Inc. from 1985 to 1997, most recently as the Vice President of Finance of its Hospital Business division. Mr. Emerson is a director of Incisive Surgical, Inc., a private company.

Lawrence Hamilton

 Mr. Lawrence W. Hamilton serves as Independent Director of Wright Medical Group Inc., since February 2007. Mr. Hamilton served as the Senior Vice President, Human Resources at Tech Data Corporation, a distributor of information technology, from 1996 to 2006, and as the Vice President, Human Resources from 1993 to 1996. Mr. Hamilton served in a variety of human resource management positions with Bristol-Myers Squibb Company from 1985 to 1993, including Vice President, Human Resources and Administration at Linvatec Corp., an arthroscopic and endoscopic division of Bristol-Myers Squibb Company, from 1991 to 1993. Mr. Hamilton is a certified Senior Professional in Human Resources and recently received the Certified Compensation Professional designation from the American Compensation Association.

Ronald Labrum

 Mr. Ronald K. Labrum is Independent Director of Wright Medical Group Inc., since February 9, 2011. Since 2007, he has served as the Chief Executive Officer of Fenwal, Inc., a provider of products and technologies that support and improve blood collection, processing and transfusion medicine. From 2004 to 2006, Mr. Labrum served as CEO of Cardinal Health, Inc.’s Healthcare Supply Chain Services, which includes medical products distribution, pharmaceutical distribution, nuclear pharmacy services and the specialty distribution businesses of Cardinal Health, Inc. During 2004, Mr. Labrum served as Chairman and CEO of Integrated Provider Solutions and Cardinal Health – International, both divisions of Cardinal Health, Inc. Prior to 2004, Mr. Labrum served as executive vice president of Cardinal Health, Inc. and Group President of the Medical Products and Services segment. Mr. Labrum joined Cardinal Health in 1999 with the acquisition of Allegiance Healthcare Corporation, originally American Hospital Supply Corp., where he was president of Allegiance Manufacturing and Distribution.

John Miclot

 Mr. John L. Miclot is Independent Director of Wright Medical Group, Inc., since March 2007. He is currently the CEO and a director at Tengion Inc., a publicly traded company that is focused on organ and cell regeneration. Prior to joining Tengion Inc. in December 2011, he was an executive in residence at Warburg-Pincus. Prior to that, he was the President and Chief Executive Officer of CCS Medical, Inc., a provider of products and services for patients with chronic diseases, from 2008 to 2010. He was the President and Chief Executive Officer of Respironics, Inc., a provider of sleep and respiratory products, from 2003 until 2008. Mr. Miclot served in various positions at Respironics, Inc. from 1998 to 2003, including Chief Strategic Officer and President of the Homecare Division. His previous employer, Healthdyne Technologies, Inc., a medical device company, was acquired by Respironics, Inc. in 1998. Mr. Miclot served as Healthdyne Technologies, Inc.’s Senior Vice President, Sales and Marketing, from 1995 to 1998. He began his medical career at DeRoyal Industries, Inc., Baxter International Inc., Ohmeda Medical, Inc., and Medix Inc. Mr. Miclot served as a director of ev3, Inc., a global endovascular device company, prior to the sale of the company in 2010. Currently, Mr. Miclot is a director of Dentsply International, a publicly traded company, chairman of the Board of Directors of Breathe Technologies, Inc., a private company, as well as a director of the Pittsburgh Zoo & PPG Aquarium and Burger King Cancer Caring Center, both charitable institutions.

Amy Paul

 Ms. Amy S. Paul serves as Independent Director of Wright Medical Group Inc., since May 2008. Ms. Paul retired in 2008 following a 26-year career with C.R. Bard, Inc., a medical device company, most recently serving as the Group Vice President-International since 2003. She served in various positions at C.R. Bard, Inc. from 1982 to 2003, including President of Bard Access Systems, Inc., President of Bard Endoscopic Technologies, Vice President and Business Manager of Bard Ventures, Vice President of Marketing of Bard Cardiopulmonary Division, Marketing Manager for Davol Inc., and Senior Product Manager for Davol Inc. Ms. Paul is a director of Viking Systems, Inc., a publicly traded company, and is a commissioner of the Northwest Commission on Colleges and Universities.

Robert Quillinan

 Mr. Robert J. Quillinan serves as Independent Director of Wright Medical Group Inc., since July 2006. He retired in 2003 following a 23-year career with Coherent, Inc., a supplier of lasers, precision optics, and related accessories used in commercial and scientific research applications. At Coherent, Inc., Mr. Quillinan served as Executive Vice President of Mergers and Acquisitions from 2002 to 2003, Executive Vice President and Chief Financial Officer from 1983 to 2002, Vice President and Treasurer from 1982 to 1983, and Corporate Controller from 1980 to 1982. He was the Director of Financial Services for Synertek, Inc. from 1978 to 1980 and an audit manager for Main, LaFrentz & Co. from 1971 to 1978. Mr. Quillinan was a director of Iverson Genetic Diagnostics, Inc., a private company, from 2009 to August 2010.

Insider Trading

Name Shares Traded Price

BERRY LANCE A

 141 $22.66

STOOKEY ERIC A

 104 $22.66

STEIGER EDWARD A

 90 $22.66

GRIFFIN WILLIAM L JR

 137 $22.70

DAVIS TIMOTHY E JR

 615 $21.24

STOOKEY ERIC A

 975 $21.23

STEIGER EDWARD A

 410 $21.21

BLACKFORD GARY D

 7,500 $15.47

BLACKFORD GARY D

 2,500 $15.50

BLACKFORD GARY D

 5,000 $18.37

WALKER JENNIFER S

 528 $21.00

BERRY LANCE A

 905 $20.99

ANDREWS JULIE

 9,524 $0.00

GRIFFIN WILLIAM L JR

 3,146 $20.38

BERRY LANCE A

 100 $20.41

WALKER JENNIFER S

 1,045 $20.39

GRIFFIN WILLIAM L JR

 100 $20.43

STOOKEY ERIC A

 1,289 $20.40

WALKER JENNIFER S

 7 $20.38

STEIGER EDWARD A

 1,777 $20.49

STOOKEY ERIC A

 320 $20.44

STOOKEY ERIC A

 200 $20.43

GRIFFIN WILLIAM L JR

 100 $20.40

DAVIS TIMOTHY E JR

 146 $20.40

STOOKEY ERIC A

 100 $20.45
» Full list on Insider Trading
Search Stocks